QC Kinetix (Avon)
About QC Kinetix (Avon)
QC Kinetix is a national leader in regenerative medicine, offering patients a drug‑free, non‑surgical alternative to traditional orthopedic care. By harnessing the body’s own biologics—such as platelet‑rich plasma, stem cells, and plasma—its treatments stimulate natural healing, reduce inflammation, and improve mobility. The practice emphasizes a patient‑first philosophy, personalized treatment plans, and a commitment to restoring quality of life without the risks and downtime of surgery. The clinic treats a comprehensive range of musculoskeletal conditions across the knee, spine, shoulder, hip, elbow, ankle & foot, and hand & wrist. Services include PRP injections, stem cell treatments, prolotherapy, Class IV laser therapy, bone‑marrow concentrate (BMAC) procedures, A2M (Alpha‑2‑macroglobulin) therapy, and plasma therapy. Patients can expect a free consultation, minimal recovery time, and a structured protocol that often yields noticeable improvement within weeks and full benefits within months. QC Kinetix’s medical team is led by board‑certified orthopedic surgeon Dr. Mitchell Sheinkop, MD, the National Medical Director, alongside physicians such as Dr. Justin Garzone, DO, Dr. Aaron Wolkoff, DO, and Dr. Ashley Caravelli, DO. The organization also includes senior consultants and executive leaders like Dr. Theodore Sand, PhD, Ali White, PA‑C, and Ginger Arntz, MSN, FNP‑C. With over 170 locations nationwide, the practice delivers consistent, evidence‑based regenerative care to patients seeking lasting pain relief.